ArticleJournal of clinical psychology in medical settings2026
Detection of Perinatal Mood and Anxiety Symptoms in Patients Presenting in a Specialty Fetal Care Center During Pregnancy.
Article in Journal of clinical psychology in medical settings, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Edinburgh Postnatal Depression Scale (EPDS) and its three-item subsection (EPDS-3A) are screening tools for perinatal depression and anxiety, respectively. There is limited research on their use in fetal care centers despite high rates of perinatal mood and anxiety disorders. This study aims to evaluate the short-term test-retest reliability of the EPDS and assess the utility of the EPDS-3A. Screening data collected during a clinical quality improvement initiative at a fetal care clinic was evaluated, including EPDS, EPDS-3A, and Generalized Anxiety Disorder-7 (GAD-7) scores. Rates of positive screens and sensitivity/specificity analyses were calculated to compare anxiety screeners. Initially the EPDS and GAD-7 were administered at every visit (visits ranged from 1 to 30 d). The EPDS-3A had good sensitivity and specificity compared against the GAD-7. When comparing either a positive score on the EPDS and/or a positive score on the EPDS-3A to the GAD-7, sensitivity increased and specificity decreased. During the study, the GAD-7 was discontinued due to redundancy, and screening cadence was reduced. The EPDS with the EPDS-3A has excellent identification of psychological distress in a fetal care center. Screening scores appear to be reliable up to one month, and more frequent administration may be unnecessary.
Indexed as
Identifiers
42622929What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.